Featured Research

from universities, journals, and other organizations

Smoking leads to five-fold increase in heart disease and stroke in under-50s

Date:
May 31, 2013
Source:
European Society of Cardiology (ESC)
Summary:
Smoking increases the risk of heart disease and stroke by five-fold in people under the age of 50 and doubles risk in the over-60s. The protection of children and adolescents from taking up smoking is essential to future health.

Smoking increases the risk of heart disease and stroke by five-fold in people under the age of 50 and doubles risk in the over-60s. The protection of children and adolescents from taking up smoking is essential to the future health of Europeans and stronger measures are needed, according to the European Society of Cardiology (ESC). The warning comes on World No Tobacco Day, held today.

Cardiovascular disease (CVD) is the number one killer in Europe and is responsible for the death of 1.9 million EU citizens every year. Smoking causes 28% of CVD deaths in men aged 35 to 69 years and 13% of CVD deaths in women of the same age.2 Risks from smoking are related to how much tobacco is smoked daily and to how long a person has been a smoker.

Professor Grethe Tell, ESC prevention spokesperson, said: "We know that the earlier one starts smoking, the more damage the smoke does. One reason is that there is a dose response relationship between how many years one smokes and the risk of cardiovascular disease, so the younger you are when you start, the higher dose you get altogether. In addition, the earlier you start smoking, the more addicted you may become and therefore the more difficult it will be to stop smoking later."

The ESC is calling for a number of measures to prevent young people from taking up smoking:3

• Ban tobacco products with a characterising flavour from the market. Flavours improve the taste and make it easier to inhale, particularly for young people just starting to smoke.

• Introduce plain packaging for tobacco products and avoid trademarks or promotional elements. Studies suggest that this will have a large impact on preventing young adults from trying smoking.

• Cover at least 75% of the front and back packaging with health warnings on the multiple risks of smoking. These warnings are particularly effective with young adults.

• Enforce age verification by retailers, with large financial penalties for underage sales.

• Introduce a requirement for medicine authorisation of all non-tobacco nicotine containing products to prevent promotion to young adults who are non-smokers.

• Regulate electronic cigarettes as a tobacco and medical product. Brands with flavours such as vanilla or chocolate attract children and put them at increased risk of experimenting with cigarettes or other nicotine containing products.

European institutions are currently working on a new "Tobacco Products Directive." The ESC is therefore calling the relevant policy-makers to include its recommendations and adopt optimal public health protection measures.

Stopping young people taking up smoking is a key goal of the ESC joint guidelines on prevention of cardiovascular disease.4 Other recommendations are to avoid smoking and exposure to passive smoking, and that all smokers should be given advice and help to quit.

Passive smoking at home or in the work place increases the risk of CVD by 30%. However, smoking bans lead to rapid and sizeable reductions in hospitalizations for acute myocardial infarction. People who stop smoking also rapidly reduce their risk of CVD.

Professor Tell said: "Passive smoking is much more dangerous than many people think. Increasing exposure to cigarette smoke, either active or passive, is significantly associated with atherosclerosis.''

She concluded: "Prevention of smoking is the most cost-effective way to treat and prevent cardiovascular disease. This is particularly important for children and adolescents who are susceptible to tobacco promotion and find it more difficult to quit smoking."


Story Source:

The above story is based on materials provided by European Society of Cardiology (ESC). Note: Materials may be edited for content and length.


Cite This Page:

European Society of Cardiology (ESC). "Smoking leads to five-fold increase in heart disease and stroke in under-50s." ScienceDaily. ScienceDaily, 31 May 2013. <www.sciencedaily.com/releases/2013/05/130531105328.htm>.
European Society of Cardiology (ESC). (2013, May 31). Smoking leads to five-fold increase in heart disease and stroke in under-50s. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/05/130531105328.htm
European Society of Cardiology (ESC). "Smoking leads to five-fold increase in heart disease and stroke in under-50s." ScienceDaily. www.sciencedaily.com/releases/2013/05/130531105328.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins